Sage Therapeutics Inc.
(SAGE)
undefined
undefined%
At close: undefined
5.38
0.75%
After-hours Dec 13, 2024, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 |
| Net Income | -541.49M | -532.78M | -457.89M | 606.07M | -680.24M | -372.88M | -270.12M | -158.99M | -94.50M | -33.81M | -18.28M | -9.63M |
| Depreciation & Amortization | 1.39M | 1.12M | 4.18M | 2.63M | 2.28M | 1.14M | 531.00K | 281.00K | 115.00K | 51.00K | 47.00K | 44.00K |
| Stock-Based Compensation | 73.37M | 61.60M | 104.63M | 95.99M | 153.23M | 101.96M | 35.53M | 23.02M | 15.24M | 2.51M | 61.00K | - |
| Other Working Capital | -58.89M | -2.76M | -6.69M | -28.22M | 25.44M | -5.33M | 18.87M | 9.68M | 4.56M | 3.64M | -81.00K | 53.00K |
| Other Non-Cash Items | -6.47M | 4.35M | -10.60M | -688.00K | -10.64M | -10.11M | -398.00K | -470.00K | 1.21M | 127.00K | 64.00K | 662.00K |
| Deferred Income Tax | - | - | - | - | - | - | - | - | - | - | - | - |
| Change in Working Capital | -67.38M | 5.67M | -18.51M | -39.73M | 6.66M | 19.21M | 15.18M | 17.48M | 7.25M | 4.08M | 593.00K | 662.00K |
| Operating Cash Flow | -540.59M | -460.04M | -378.18M | 664.28M | -528.71M | -260.67M | -219.28M | -118.68M | -70.68M | -27.04M | -17.52M | -8.93M |
| Capital Expenditures | -553.00K | -937.00K | -372.00K | -345.00K | -5.75M | -2.86M | -1.36M | -1.42M | -198.00K | -128.00K | -3.00K | -111.00K |
| Acquisitions | - | -326.37M | 1.00B | -443.03M | 137.41M | - | - | - | - | - | - | - |
| Purchase of Investments | -594.67M | -881.04M | -1.99B | -458.72M | -1.31B | -1.48B | -244.40M | -259.09M | - | - | - | - |
| Sales Maturities Of Investments | 1.04B | 1.21B | 988.08M | 901.75M | 1.17B | 974.76M | 261.23M | 30.50M | - | - | - | - |
| Other Investing Acitivies | - | 326.37M | -1.00B | 443.03M | -137.41M | -509.60M | -285.00K | -525.00K | - | - | - | - |
| Investing Cash Flow | 442.91M | 325.43M | -1.00B | 442.68M | -143.16M | -512.46M | 15.18M | -230.54M | -198.00K | -128.00K | -3.00K | -111.00K |
| Debt Repayment | - | - | - | - | - | - | - | - | - | - | - | - |
| Common Stock Repurchased | -903.00K | -43.00K | -1.39M | - | - | - | - | - | - | - | - | - |
| Dividend Paid | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Financial Acitivies | 6.03M | 3.07M | 13.33M | 9.26M | 46.35M | 27.86M | 15.79M | 807.00K | 146.00K | 50.62M | 22.73M | 8.99M |
| Financial Cash Flow | 6.03M | 3.07M | 13.33M | 426.76M | 607.62M | 659.36M | 341.82M | 330.98M | 129.87M | 146.87M | 22.78M | 9.00M |
| Net Cash Flow | -91.64M | -131.53M | -1.37B | 1.53B | -64.24M | -113.77M | 137.72M | -18.24M | 58.99M | 119.70M | 5.26M | -40.00K |
| Free Cash Flow | -541.14M | -460.97M | -378.55M | 663.93M | -534.46M | -263.53M | -220.64M | -120.10M | -70.88M | -27.17M | -17.52M | -9.04M |